Medullary thyroid carcinoma is associated with-
**Question:** Medullary thyroid carcinoma is associated with-
A. Multiple Endocrine Neoplasia syndrome type 2 (MEN2)
B. Familial adenomatous polyposis (FAP)
C. Proteus syndrome
D. Von Hippel-Lindau disease
**Core Concept:** Medullary thyroid carcinoma (MTC) is a type of thyroid cancer that arises from the parafollicular C cells of the thyroid gland. These cells are responsible for producing calcitonin, a hormone involved in calcium regulation.
**Why the Correct Answer is Right:**
Medullary thyroid carcinoma is primarily associated with Multiple Endocrine Neoplasia syndrome type 2 (MEN2), which is a genetic disorder characterized by the development of tumors in multiple endocrine glands. MEN2 is caused by mutations in the RET proto-oncogene, which leads to unregulated cell growth and the formation of tumors, including MTC.
**Why Each Wrong Option is Incorrect:**
B. Familial adenomatous polyposis (FAP) is a condition characterized by the development of colorectal polyps and an increased risk of colorectal cancer. It is unrelated to thyroid cancer and does not involve the RET proto-oncogene.
C. Proteus syndrome is a rare genetic disorder characterized by disproportionate overgrowth, which is unrelated to thyroid cancer and does not involve genetic mutations in RET or other thyroid-related genes.
D. Von Hippel-Lindau disease is a genetic disorder characterized by the development of tumors in multiple organs, including the kidneys, retina, and central nervous system. It is unrelated to thyroid cancer and does not involve genetic mutations in RET or other thyroid-related genes.
**Clinical Pearl:** The association between MTC and MEN2 highlights the importance of genetic testing and prophylactic thyroidectomy in high-risk individuals, such as those with a family history of MTC or MEN2, to prevent the development and progression of this cancer.
**Correct Answer:** A. MEN2
**Core Concept:** The correct answer, MEN2, is a genetic disorder that increases the risk of developing MTC due to mutations in the RET proto-oncogene. Unregulated cell growth caused by these mutations results in the formation of tumors, including MTC.